<GlossaryTerm id="CDR0000779792"><TermName>Evomela</TermName><TermPronunciation>(eh-voh-MEH-lah)</TermPronunciation><TermDefinition><DefinitionText>A drug that contains the active ingredient melphalan hydrochloride and is given as an infusion to prepare patients with multiple myeloma for a stem cell transplant. It is also being studied in the treatment of other types of cancer. Evomela may kill cancer cells by damaging their DNA and stopping them from dividing. It is a type of alkylating agent.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000780304" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Evomela&quot;" language="en" id="_3"/><MediaLink ref="CDR0000780303" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Evomela&quot;" language="es" id="_4"/><SpanishTermName>Evomela</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que contiene el principio activo clorhidrato de melfalán. Se administra mediante infusión para preparar a los pacientes con mieloma múltiple que van a recibir un transplante de células madre. También está en estudio para el tratamiento de otros tipos de cáncer. Es posible que Evomela destruya células cancerosas al dañar su ADN e impedir que se multipliquen. Es un tipo de alquilante.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2016-03-28</DateFirstPublished><RelatedInformation><RelatedDrugSummaryRef UseWith="en" href="CDR0000779087" url="/about-cancer/treatment/drugs/melphalan-hydrochloride">Melphalan Hydrochloride</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
